Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATLong-Term Debt IssuancesRent Expense
Ratios

Avai Bio (AVAI) Depreciation Expense (2018 - 2020)

Avai Bio's Depreciation Expense history spans 3 years, with the latest figure at $14378.0 for Q4 2020.

  • For Q4 2020, Depreciation Expense rose 75.56% year-over-year to $14378.0; the TTM value through Dec 2020 reached $56949.0, up 154.73%, while the annual FY2024 figure was $1500.0, N/A changed from the prior year.
  • Depreciation Expense for Q4 2020 was $14378.0 at Avai Bio, up from $14256.0 in the prior quarter.
  • Across five years, Depreciation Expense topped out at $16748.0 in Q1 2020 and bottomed at $2165.0 in Q4 2018.
  • The 3-year median for Depreciation Expense is $9837.0 (2019), against an average of $9052.3.
  • The largest YoY upside for Depreciation Expense was 673.58% in 2020 against a maximum downside of 44.92% in 2020.
  • A 3-year view of Depreciation Expense shows it stood at $2165.0 in 2018, then surged by 278.29% to $8190.0 in 2019, then surged by 75.56% to $14378.0 in 2020.
  • Per Business Quant, the three most recent readings for AVAI's Depreciation Expense are $14378.0 (Q4 2020), $14256.0 (Q3 2020), and $11567.0 (Q2 2020).